Continuse Biometrics, Ltd.
IsraelFDA applicant, unverified
- Devices
- 1
What Continuse Biometrics, Ltd. makes
Continuse Biometrics, Ltd. manufactures the Gili Pro BioSensor, a wearable biosensor system designed for continuous, non-invasive monitoring of physiological parameters such as heart rate and other vital signs.
The Gili Pro BioSensor is classified as a Class II medical device in the US and is listed under the FDA’s 510(k) premarket notification process. The company is based in the United States.
Catalogue
Gili Pro BioSensor (also known as Gili BioSensor System) Ref DEN200038
Regimes: De Novo Registry: De Novo
Frequently asked questions
How many devices does Continuse Biometrics, Ltd. have in the registry?
The registry currently lists 1 device for Continuse Biometrics, Ltd.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Continuse Biometrics, Ltd.'s devices?
Among its 1 most recently registered device, Continuse Biometrics, Ltd. has devices listed in FDA 510(k) (1 device).
What risk classes do Continuse Biometrics, Ltd.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Continuse Biometrics, Ltd.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Continuse Biometrics, Ltd. in the registry?
The most recently registered devices listed for Continuse Biometrics, Ltd. include Gili Pro BioSensor (also known as “Gili BioSensor System”).